Jupiter Asset Management Ltd. Raises Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jupiter Asset Management Ltd. boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1,673.2% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 191,751 shares of the medical instruments supplier’s stock after acquiring an additional 180,937 shares during the quarter. Jupiter Asset Management Ltd.’s holdings in DENTSPLY SIRONA were worth $12,234,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XRAY. First Trust Advisors LP grew its holdings in DENTSPLY SIRONA by 203.9% in the first quarter. First Trust Advisors LP now owns 91,083 shares of the medical instruments supplier’s stock worth $4,517,000 after purchasing an additional 61,111 shares during the last quarter. Amundi Pioneer Asset Management Inc. lifted its stake in shares of DENTSPLY SIRONA by 39.9% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 184,628 shares of the medical instruments supplier’s stock worth $9,157,000 after buying an additional 52,645 shares during the period. Comerica Bank lifted its stake in shares of DENTSPLY SIRONA by 28.8% during the fourth quarter. Comerica Bank now owns 59,576 shares of the medical instruments supplier’s stock worth $3,410,000 after buying an additional 13,317 shares during the period. California Public Employees Retirement System lifted its stake in shares of DENTSPLY SIRONA by 5.7% during the fourth quarter. California Public Employees Retirement System now owns 536,321 shares of the medical instruments supplier’s stock worth $28,082,000 after buying an additional 29,025 shares during the period. Finally, Daiwa Securities Group Inc. lifted its stake in shares of DENTSPLY SIRONA by 154.8% during the fourth quarter. Daiwa Securities Group Inc. now owns 26,510 shares of the medical instruments supplier’s stock worth $1,388,000 after buying an additional 16,107 shares during the period. 94.50% of the stock is currently owned by institutional investors and hedge funds.

XRAY stock opened at $66.07 on Friday. The stock has a market capitalization of $14.42 billion, a PE ratio of 83.63, a P/E/G ratio of 1.10 and a beta of 0.93. The stock’s 50-day moving average is $66.31. The company has a quick ratio of 0.99, a current ratio of 1.40 and a debt-to-equity ratio of 0.39. DENTSPLY SIRONA Inc. has a 52 week low of $40.15 and a 52 week high of $69.54.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 6th. The medical instruments supplier reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.55 by $0.17. The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $944.89 million. DENTSPLY SIRONA had a net margin of 4.99% and a return on equity of 9.45%. The company’s quarterly revenue was up 17.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.43 earnings per share. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post 2.86 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 9th. Investors of record on Friday, June 25th will be paid a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a yield of 0.67%. The ex-dividend date is Thursday, June 24th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.10. DENTSPLY SIRONA’s dividend payout ratio is currently 22.35%.

In related news, insider Walter Petersohn sold 17,425 shares of the stock in a transaction on Tuesday, May 25th. The shares were sold at an average price of $67.40, for a total value of $1,174,445.00. Following the transaction, the insider now directly owns 55,222 shares of the company’s stock, valued at approximately $3,721,962.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Eric Brandt sold 7,600 shares of the firm’s stock in a transaction on Wednesday, March 17th. The stock was sold at an average price of $63.21, for a total transaction of $480,396.00. Following the transaction, the director now directly owns 38,131 shares in the company, valued at $2,410,260.51. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by corporate insiders.

Several research firms have recently commented on XRAY. Robert W. Baird lifted their price objective on shares of DENTSPLY SIRONA from $71.00 to $78.00 and gave the stock an “outperform” rating in a research note on Friday, May 7th. Barrington Research boosted their target price on shares of DENTSPLY SIRONA from $71.00 to $77.00 and gave the company an “outperform” rating in a research report on Friday, May 7th. HC Wainwright upped their price objective on shares of DENTSPLY SIRONA from $60.00 to $72.00 and gave the stock a “neutral” rating in a research report on Friday, May 7th. Barclays upped their price objective on shares of DENTSPLY SIRONA from $50.00 to $55.00 and gave the stock an “underweight” rating in a research report on Tuesday, March 2nd. Finally, Piper Sandler upped their price objective on shares of DENTSPLY SIRONA from $70.00 to $75.00 and gave the stock an “overweight” rating in a research report on Thursday, May 6th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $62.11.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Article: What is the price-to-earnings growth (PEG) ratio?

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.